CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) has earned an average recommendation of “Hold” from the five analysts that are presently covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating. The average 1-year price objective among analysts that have covered the stock in the last year is $117.00.
A number of research firms have recently weighed in on CHEOY. Canaccord Genuity Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 18th. Zacks Research upgraded CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. Royal Bank Of Canada cut CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target on the stock. in a report on Thursday, July 16th. Finally, Jefferies Financial Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd.
Read Our Latest Report on CochLear
CochLear Stock Performance
CochLear Company Profile
Cochlear Limited is an Australian medical technology company that develops, manufactures and supplies implantable hearing solutions for people with moderate to profound hearing loss. Its products are designed to help restore access to sound for individuals who may not benefit sufficiently from conventional hearing aids.
The company’s product portfolio includes cochlear implants, sound processors, bone-conduction hearing implants and related accessories and services. Cochlear also provides professional support, rehabilitation resources and connectivity solutions for recipients, hearing-health specialists and caregivers.
Founded in 1981 and headquartered in Sydney, Australia, Cochlear traces its origins to research led by Professor Graeme Clark, whose work contributed to the development of the world’s first multichannel cochlear implant.
Recommended Stories
- Five stocks we like better than CochLear
- 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
